Lanzavecchia Antonio, Sallusto Federica
Institute for Research in Biomedicine, Via Vincenzo Vela 6, Bellinzona, Switzerland.
Curr Opin Immunol. 2007 Jun;19(3):268-74. doi: 10.1016/j.coi.2007.04.002. Epub 2007 Apr 12.
It has been known for almost 30 years that mouse B cells proliferate and differentiate to antibody-secreting cells when stimulated by microbial products such as lipopolysaccharide or CpG-containing DNA, but the relevance of these polyclonal responses remained elusive until recently. A breakthrough in the field has been the discovery of endosomal Toll-like receptors in B cells and their role in the production of autoantibodies. Since then, several reports have extended the role of Toll-like receptors in B-cell responses to thymus-independent and thymus-dependent antigens, and in antibody class switch in lymphoid and extralymphoid tissues. Considering the complexity of the system it is perhaps not surprising that the literature contains some contradictory findings. However, the scientific fecundity in this rapidly evolving field will probably give rise to discoveries that could be translated into more effective vaccines and immunotherapies.
近30年来,人们已经知道,当受到脂多糖或含CpG的DNA等微生物产物刺激时,小鼠B细胞会增殖并分化为抗体分泌细胞,但直到最近,这些多克隆反应的相关性仍不明确。该领域的一个突破是在B细胞中发现了内体Toll样受体及其在自身抗体产生中的作用。从那时起,一些报告扩展了Toll样受体在B细胞对非胸腺依赖性和胸腺依赖性抗原的反应以及在淋巴组织和非淋巴组织中的抗体类别转换中的作用。考虑到该系统的复杂性,文献中存在一些相互矛盾的发现或许并不奇怪。然而,这个快速发展的领域中的科学活力可能会带来一些发现,这些发现可以转化为更有效的疫苗和免疫疗法。